M1 muscarinic cetylcholine receptor allosteric modulators as potential therapeutic opportunities for treating Alzheimer's disease

Michael Decker, Ulrike Holzgrabe
  • MedChemComm, January 2012, Royal Society of Chemistry
  • DOI: 10.1039/c2md20025b
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: